Press
If you would like to discuss anything press related, please email press@rarecan.com
RareCan in the news
Atelerix and RareCan press release – https://www.atelerix.co.uk/atelerix-rarecan-press-release/
Sarcoma UK announces partnership with RareCan – 25th July 2023 – https://sarcoma.org.uk/news/sarcoma-uk-announces-partnership-with-rarecan-to-help-grow-its-community-and-improve-opportunities-for-clinical-trial-participation/
Neuroendocrine Cancer UK announces partnership with RareCan – 10th July 2023 – https://www.neuroendocrinecancer.org.uk/neuroendocrine-cancer-uk-announces-partnership-with-rarecan/
NS Healthcare – https://www.ns-healthcare.com/news/blood-cancer-uk-rarecan-renew-partnership-to-expedite-cancer-research/#
PharmaTimes – 23rd June 2023 – https://www.pharmatimes.com/news/blood_cancer_uk_extends_collaboration_with_rarecan_1493790
Blood Cancer UK – 23rd June 2023 – https://bloodcancer.org.uk/news/blood-cancer-uk-renews-partnership-with-rarecan-to-accelerate-research-into-rare-cancers/
Business Live – 1st March 2023 – RareCan eyes up to 3m investment this year
Barclays Eagle Labs – 22nd July 2022 – How our health tech startup secured public sector partnerships
UK Business Angels Association – 5 July 2022 – Newcastle – based Rare Cancer Research Start-Up RareCan Secures Six Figure Investment to Grow Business
Britain Daily – 30 June 2022 – House Music Pioneer and Star DJ Sasha to Play Intimate Gig to Help Dad Speed Up Research into Rare Cancers
Newcastle University – 28 June 2022 – Retired Professor sets up Business to Accelerate Rare Cancer Research
Innovation Super Network North East England – 27 June 2022 – Newcastle Based Rare Cancer Research Start Up Secures Six Figure Investment to Grow Business
Inside Media – 24 June 2022 – Medical Research Platform Smashes Crowdfunding Target
Business Live – 20 June 2022 – Female angel syndicate helps Northern founders raise almost £2.5m in first year
National Health Executive – 24 January 2022 – Digitalisation of Clinical Trials
Novopath – 9 December 2021 – Novopath & RareCan Research and Innovation Collaboration
Newcastle Chronicle – 25 November – Inside the Newcastle ‘BioBank’ of blood and tissue samples which could help cure rare cancers
Drug Discovery World – 23 November – Accelerating Research: The Path Forward for Treating Rare Cancers
Adlib Recruitment – 19th November – Product People Potential – Our Chat with RareCan Limited
weareumi – 10th November – Go Further Investment Index Celebrates most Progressive Northern UK Businesses
EPM Magazine – 9th November – Blood Cancer UK Partners with RareCan to Improve Delivery of Clinical Trials
Technology Networks – 9th November – RareCan Receives Approval from NHS Research Ethics Committee to Establish Vital BioResource at Newcastle University
Northern Echo – 4th November – Teesside University New Cancer Treatment Research Partnership
PharmaTimes – 2nd November 2021 – Putting Digitally Empowered Patients at the Core of Rare Cancer Research
Drug Discovery World – 26th October 2021 – RareCan Receives approval to establish BioResource at Newcastle University
Newcastle Chronicle – 5th October 2021 – Newcastle professor’s ‘matchmaking’ site helps patients with rare cancers find the clinical trials that could save their lives
Pharmafile – 25th August 2021 – RareCan appoints Dr Anita Cooper
Drug Discovery World – 4th August 2021 – Appointment strenghtens the experience of RareCanGMe

Star DJ and house music pioneer Sasha to play gig to help his Dad speed up Rare Cancer research
Star DJ and house music pioneer, Sasha, to play gig to help his dad speed up rare cancer research By RareCan Team on 4th July

RareCan Launches Crowdfunding Campaign
Hexham, UK, 21 June 2022: RareCan, a direct-to-patient clinical trial recruitment platform bringing together the power of patients and their data to reduce the costs

RareCan partners with Blood Cancer UK to accelerate research into rare cancers
Hexham, UK, 08 November 2021: RareCan, a novel company accelerating research into rare cancers, today announced it has partnered with leading UK-based charity, Blood Cancer

RareCan receives approval from NHS Research Ethics Committee to establish vital BioResource at Newcastle University
RareCan receives approval from NHS Research Ethics Committee to establish vital BioResource at Newcastle University Hexham, UK, 25 October 2021: RareCan, a novel company accelerating

RareCan appoints Dr Anita Cooper as Non-Executive Director
RareCan appoints Dr Anita Cooper as Non-Executive Director Hexham, UK, 2nd August 2021: RareCan, a new and innovative company accelerating research into rare cancers, today

Mandashi Invests in RareCan
Mandashi Invests in RareCan We urgently need to increase treatment options and improve outcomes for people with rare cancer. At RareCan, we are working with